Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS2 | Q9H2K2 | 18/20 | 0.60 |
| ▸ | TNKS | O95271 | 8/20 | 0.60 |
| ▸ | WNT3A | P56704 | 12/20 | 0.57 |
| ▸ | PARP1 | P09874 | 4/20 | 0.57 |
| ▸ | PARP2 | Q9UGN5 | 3/20 | 0.57 |
| ▸ | PARP3 | Q9Y6F1 | 2/20 | 0.57 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.57 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.57 |
| ▸ | AXIN2 | Q9Y2T1 | 1/20 | 0.57 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.45 |
| ▸ | SPR | P35270 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30870711 | 1.00 | TNKS2 (0.60) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL27440687 | 0.91 | TNKS2 (0.53) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL27439780 | 0.89 | TNKS2 (0.53) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL30870652 | 0.89 | TNKS2 (0.53) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL27440061 | 0.86 | TNKS2 (0.61) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL30870713 | 0.86 | TNKS2 (0.61) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL30870717 | 0.86 | TNKS2 (0.56) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL27440462 | 0.86 | TNKS2 (0.56) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL30870640 | 0.86 | TNKS2 (0.60) | TNKS2TNKSWNT3APARP1PARP2 | |
| SCHEMBL27440909 | 0.86 | TNKS2 (0.60) | TNKS2TNKSWNT3APARP1PARP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024086246-A2 | 2-SUBSTITUTED 3,4 A, 5, 7, 8, 8 A-HEXAHYDRO-4H-THIOP YRANO [4,3- DJPYRIMIDIN-4-ONES FOR WOUND TREATMENT | Eluciderm Inc. (US) | 2024-04-25 | — | — | WO | disclosed |